Pinyo Rattanaumpawan1, Irving Nachamkin2, Warren B Bilker3, Jason A Roy3, Joshua P Metlay4, Theoklis E Zaoutis5, Ebbing Lautenbach6. 1. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand pinyo@mail.med.upenn.edu. 2. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA. 3. Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, USA. 4. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. 5. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. 6. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Abstract
OBJECTIVES: The prevalence of high-MIC fluoroquinolone-susceptible Escherichia coli (FQSEC) has been increasing. These isolates are one step closer to full fluoroquinolone (FQ) resistance and may lead to delayed response to FQ therapy. Our study aimed to investigate the epidemiology of high-MIC FQSEC in ambulatory urinary tract infections (UTIs). PATIENTS AND METHODS: A case-control study was conducted at outpatient services within the University of Pennsylvania Health System, Philadelphia. All female subjects with non-recurrent UTI caused by FQSEC (levofloxacin MIC < 4 mg/L) were enrolled. Cases were subjects with high-MIC FQSEC UTI (levofloxacin MIC >0.12 but < 4 mg/L) and controls were subjects with low-MIC FQSEC UTI (levofloxacin MIC ≤0.12 mg/L). Data on microbiology results and baseline characteristics were extracted from electronic medical records. RESULTS: During the 3 year study period (May 2008-April 2011), 11 287 episodes of E. coli bacteriuria were identified. The prevalence of FQSEC, FQ-intermediate susceptible E. coli and FQ-resistant E. coli was 75.0%, 0.4% and 24.6%, respectively. A total of 2001 female subjects with FQSEC UTI were enrolled into our study (165 cases and 1836 controls). Independent risk factors for high-MIC FQ susceptibility included Asian race (OR = 2.92; 95% CI = 1.29-6.58; P = 0.02), underlying renal disease (OR = 2.18; 95% CI = 1.15-4.14; P = 0.02) and previous nitrofurantoin exposure (OR = 8.86; 95% CI = 1.95-40.29; P = 0.005). CONCLUSIONS: Asian race, underlying renal disease and previous exposure to nitrofurantoin were identified as independent risk factors for high-MIC FQSEC. There may be some factors that are more common in Asians, which may result in the selection of high-MIC FQSEC. Further studies are necessary to explore these findings.
OBJECTIVES: The prevalence of high-MIC fluoroquinolone-susceptible Escherichia coli (FQSEC) has been increasing. These isolates are one step closer to full fluoroquinolone (FQ) resistance and may lead to delayed response to FQ therapy. Our study aimed to investigate the epidemiology of high-MIC FQSEC in ambulatory urinary tract infections (UTIs). PATIENTS AND METHODS: A case-control study was conducted at outpatient services within the University of Pennsylvania Health System, Philadelphia. All female subjects with non-recurrent UTI caused by FQSEC (levofloxacin MIC < 4 mg/L) were enrolled. Cases were subjects with high-MIC FQSEC UTI (levofloxacin MIC >0.12 but < 4 mg/L) and controls were subjects with low-MIC FQSEC UTI (levofloxacin MIC ≤0.12 mg/L). Data on microbiology results and baseline characteristics were extracted from electronic medical records. RESULTS: During the 3 year study period (May 2008-April 2011), 11 287 episodes of E. coli bacteriuria were identified. The prevalence of FQSEC, FQ-intermediate susceptible E. coli and FQ-resistant E. coli was 75.0%, 0.4% and 24.6%, respectively. A total of 2001 female subjects with FQSEC UTI were enrolled into our study (165 cases and 1836 controls). Independent risk factors for high-MIC FQ susceptibility included Asian race (OR = 2.92; 95% CI = 1.29-6.58; P = 0.02), underlying renal disease (OR = 2.18; 95% CI = 1.15-4.14; P = 0.02) and previous nitrofurantoin exposure (OR = 8.86; 95% CI = 1.95-40.29; P = 0.005). CONCLUSIONS: Asian race, underlying renal disease and previous exposure to nitrofurantoin were identified as independent risk factors for high-MIC FQSEC. There may be some factors that are more common in Asians, which may result in the selection of high-MIC FQSEC. Further studies are necessary to explore these findings.
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: L C McDonald; F J Chen; H J Lo; H C Yin; P L Lu; C H Huang; P Chen; T L Lauderdale; M Ho Journal: Antimicrob Agents Chemother Date: 2001-11 Impact factor: 5.191
Authors: Daniel J Skiest; Katia Brown; Travis W Cooper; Holly Hoffman-Roberts; Huda R Mussa; Alan C Elliott Journal: J Infect Date: 2006-10-27 Impact factor: 6.072
Authors: Leanne B Gasink; Neil O Fishman; Irving Nachamkin; Warren B Bilker; Ebbing Lautenbach Journal: Infect Control Hosp Epidemiol Date: 2007-08-03 Impact factor: 3.254
Authors: Bernard C Camins; Monica M Farley; John J Jernigan; Susan M Ray; James P Steinberg; Henry M Blumberg Journal: Infect Control Hosp Epidemiol Date: 2007-06-29 Impact factor: 3.254
Authors: U V Ukah; M Glass; B Avery; D Daignault; M R Mulvey; R J Reid-Smith; E J Parmley; A Portt; P Boerlin; A R Manges Journal: Epidemiol Infect Date: 2017-12-12 Impact factor: 4.434
Authors: Pinyo Rattanaumpawan; Irving Nachamkin; Warren B Bilker; Jason A Roy; Joshua P Metlay; Theoklis E Zaoutis; Ebbing Lautenbach Journal: Ann Clin Microbiol Antimicrob Date: 2017-04-08 Impact factor: 3.944